Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

NCT07684560 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Spontaneous Urticaria (CSU)
Healthy Volunteers

Interventions

DRUG: Alpha-0261
OTHER: Placebo

Sponsor

AlphaMol Science Ltd. (Shanghai)